Search

Search Results

• CO13 | Genetic background in hypercholesterolemic patients framing cardiovascular risk A. Kura¹, E. Sticchi², G. Barbieri¹, R. Orsi¹, S. Suraci¹, G.M. Scaturro³, E. Lotti⁴, F. Crudele⁴, M. Berteotti², A.M. Gori², R. Marcucci², B. Giusti² | ¹Department of Experimental and Clinical Medicine, Firenze; ²Department of Experimental and Clinical Medicine, Atherothrombotic Diseases Center, Careggi Hospital, Firenze; ³Meyer Children’s Hospital IRCCS, Firenze; ⁴Atherothrombotic Diseases Center, Careggi Hospital, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.217

  733

  PDF: 34

• CO07 | Real word management of anticoagulant therapy in brain metastasis: moving toward a multidisciplinary approach in complex cases E. Lotti¹, C. Manneschi², S. Fancelli², F. Scolari¹, F. Crudele¹, D. Poli¹, M. Berteotti¹, D. Rossini³, S. Pillozzi², L. Antonuzzo^2,3, R. Marcucci^1,3 | ¹Disease Unit, Careggi University Hospital, Firenze; ²Oncology Unit, Careggi University Hospital, Firenze; ³Department of Experimental and Clinical Biomedical Sciences, University of Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.211

  632

  PDF: 26

• CO045 | BEYOND THE VISIBLE: LIPOPROTEIN(a) AS A SILENT DRIVER OF RETINAL VASCULAR DAMAGE L. Agrelli¹, M. Berteotti², E. Lotti², F. Crudele², D. Poli², A.M. Gori², A Rogolino², D. Prisco², R. Marcucci² | ¹Department of Internal Medicine, University of Salerno, Italy; ²Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, AOU Careggi, Firenze, Italy

  Lucia Agrelli

  26-10-2026

  https://doi.org/10.4081/btvb.2026.747

  49

  PDF: 32

• CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS J. Patrussi¹, A. Vignoli^1|2, L. Tenori^1|2, A. Sorrentino³, M. Berteotti^3|4, E. Lotti⁴, F. Crudele⁴, G. Ciarrocca Taranta³, A.A. Rogolino⁴, G. Barbieri³, A.M. Gori^3|4, R. Marcucci^3|4 | ¹Dep. of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy; ²Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; ³Dep. of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ⁴Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  Andrea Sorrentino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.780

  58

  PDF: 17
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  https://doi.org/10.4081/btvb.2022.50

  1907

  PDF: 654

• CO021 | TIME COURSE OF LP(a) LEVELS AFTER ACUTE CORONARY SYNDROME: A LONGITUDINAL STUDY G. Barbieri¹, A.M. Gori¹, G. Ciarrocca Taranta¹, M. Di Gioia¹, F. Alfano¹, E. Lotti¹, A. Rogolino¹, F. Cesari¹, B. Giusti¹, M. Berteotti¹, R. Marcucci¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy

  Giulia Barbieri

  26-10-2026

  https://doi.org/10.4081/btvb.2026.723

  58

  PDF: 21

• PO134 | FAMILIAL HYPERCHOLESTEROLEMIA 57-GENE PANEL MUTATIONAL ANALYSIS: INSIGHT INTO CARDIOVASCULAR RISK GENETIC PREDISPOSITION A. Kura¹, E. Sticchi¹, G. Barbieri¹, F. Basso¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Ada Kura

  26-10-2026

  https://doi.org/10.4081/btvb.2026.950

  41

  PDF: 26

• CO060 | LP(a) AND CARDIOVASCULAR RISK IN FAMILIAL HYPERCHOLESTEROLEMIA F. Basso¹, G. Barbieri¹, E. Sticchi¹, A. Kura¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Francesca Basso

  26-10-2026

  https://doi.org/10.4081/btvb.2026.762

  54

  PDF: 30

• CO070 | PLASMIN GENERATION AND ITS INTERPLAY WITH COAGULATION AND FIBRINOLYSIS IN ATRIAL FIBRILLATION: IMPACT OF ANTICOAGULANT THERAPY G. Ciarrocca Taranta¹, F. Alfano¹, M. Di Gioia², M. Berteotti^1|2, E. Lotti², F. Cesari², A. Rogolino², F.A. Barbuto¹, A. M Gori^1|2, E. Sticchi^1|2, B. Giusti^1|2, R. Marcucci^1|2 | ¹Dep of Experimental and Clinical Medicine, University of Florence, Italy; ²Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.772

  58

  PDF: 27